日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Effectiveness and Safety of Telmisartan Plus Amlodipine Compared to Telmisartan Plus Cilnidipine in Indian Patients with Hypertension and Renal Impairment: A Randomized, Open Label, Post Marketing Study (START Renal)

替米沙坦联合氨氯地平与替米沙坦联合西尼地平治疗印度高血压合并肾功能不全患者的疗效和安全性比较：一项随机、开放标签、上市后研究（START Renal）

期刊:International Journal of Nephrology and Renovascular Disease
影响因子:2.5
doi:10.2147/IJNRD.S555573
Jadhav, Uday; Guha, Santanu; Mittal, Harsh; Barik, Chinmoy; Gillurkar, Chandrashekhar S; Gupta, Sandeep Kumar; Gupta, Mukulesh; Saklecha, Santosh; Jadhav, Mayur; Choudhari, Sanjay Y; Patil, Saiprasad; Bhushan, Sumit; A, Divakar; Barkate, Hanmant
心血管
高血压
STAR
发表日期：2026
文献求助 收藏

Projected Health System and Economic Impacts of 2025 Medicaid Policy Proposals

2025年医疗补助政策提案对医疗系统和经济的预期影响

期刊:JAMA Health Forum
影响因子:11.3
doi:10.1001/jamahealthforum.2025.3187
Basu, Sanjay Y; Patel, Sadiq; Berkowitz, Seth A
发表日期：2025
文献求助 收藏

Innovatively Bridging Gaps in Aesthetic Surgery Training: Insights and Initiatives

创新性地弥合美容外科培训差距：见解与举措

期刊:Indian Journal of Plastic Surgery
影响因子:1.5
doi:10.1055/s-0044-1785669
Saha, Shivangi; Kumar, Neeraj; Parashar, Sanjay Y; Singhal, Maneesh
发表日期：2024
文献求助 收藏

Efficacy and Safety of Pregabalin Prolonged Release-Etoricoxib Combination Compared to Etoricoxib for Chronic Low Back Pain: Phase 3, Randomized Study

普瑞巴林缓释片联合依托考昔治疗慢性腰痛的疗效和安全性与依托考昔单药治疗的疗效和安全性比较：一项3期随机研究

期刊:Pain and Therapy
影响因子:3.3
doi:10.1007/s40122-022-00437-2
Yeole, Amit B; Sree Ranga Lakshmi, G; Selvakumar, C J; Goni, Vijay G; Nawal, C L; Valya, Bhanoth J; Patel, Brijesh J; Patel, Rohit D; Pawar, Eknath D; Panigrahi, Ranajit; Kumar, Ashish Y; Shintre, Shrinivas S; Devkare, Prashant H; Dharmadhikari, Shruti K; Choudhari, Sanjay Y; Doshi, Maulik S; Mehta, Suyog C; Joglekar, Sadhna J
发表日期：2022
文献求助 收藏

A Prospective Multicentric Postmarketing Observational Study to Characterize the Patient Population with Reduced Gastrointestinal Motility among Indian Diabetic Patients Receiving Itopride: The Progress Study

一项前瞻性多中心上市后观察性研究，旨在描述接受伊托必利治疗的印度糖尿病患者中胃肠动力减弱的患者群体特征：进展研究

期刊:International Journal of Applied and Basic Medical Research
影响因子:0.8
doi:10.4103/ijabmr.IJABMR_351_18
Rai, Ramesh Roop; Choubal, Chittaranjan C; Agarwal, Mukesh; Khaliq, Abdul M; Farishta, Faraz J; Harwani, Yogesh P; Kumar, Sanjay Y
糖尿病
代谢
发表日期：2019
文献求助 收藏